Regulation of human and mouse bystander T cell activation responses by PD-1.
Adaptive immunity
Cytokines
Immunology
T cells
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
22 09 2023
22 09 2023
Historique:
received:
21
06
2023
accepted:
15
08
2023
medline:
25
9
2023
pubmed:
22
9
2023
entrez:
22
9
2023
Statut:
epublish
Résumé
Bystander activation of memory T cells occurs via cytokine signaling alone in the absence of T cell receptor (TCR) signaling and provides a means of amplifying T cell effector responses in an antigen-nonspecific manner. While the role of Programmed Cell Death Protein 1 (PD-1) on antigen-specific T cell responses is extensively characterized, its role in bystander T cell responses is less clear. We examined the role of the PD-1 pathway during human and mouse non-antigen-specific memory T cell bystander activation and observed that PD-1+ T cells demonstrated less activation and proliferation than activated PD-1- populations in vitro. Higher activation and proliferative responses were also observed in the PD-1- memory population in both mice and patients with cancer receiving high-dose IL-2, mirroring the in vitro phenotypes. This inhibitory effect of PD-1 could be reversed by PD-1 blockade in vivo or observed using memory T cells from PD-1-/- mice. Interestingly, increased activation through abrogation of PD-1 signaling in bystander-activated T cells also resulted in increased apoptosis due to activation-induced cell death (AICD) and eventual T cell loss in vivo. These results demonstrate that the PD-1/PD-Ligand 1 (PD-L1) pathway inhibited bystander-activated memory T cell responses but also protected cells from AICD.
Identifiants
pubmed: 37737264
pii: 173287
doi: 10.1172/jci.insight.173287
pmc: PMC10561715
doi:
pii:
Substances chimiques
Programmed Cell Death 1 Receptor
0
Cytokines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : P01 AI056299
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA214048
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL140921
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA093373
Pays : United States
Références
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Exp Med. 2003 Jul 7;198(1):71-8
pubmed: 12847138
Aging Cell. 2016 Apr;15(2):291-300
pubmed: 26750587
J Virol. 2007 Nov;81(21):11749-57
pubmed: 17804505
Immunity. 2015 Aug 18;43(2):240-50
pubmed: 26231116
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Clin Exp Immunol. 2014 Jan;175(1):79-91
pubmed: 23937663
J Clin Oncol. 2020 May 20;38(15):1655-1663
pubmed: 32053428
J Virol. 2001 Jul;75(13):5965-76
pubmed: 11390598
J Virol Methods. 2006 Feb;131(2):122-9
pubmed: 16140399
Nat Rev Immunol. 2018 Mar;18(3):153-167
pubmed: 28990585
Blood. 2021 Sep 2;138(9):806-810
pubmed: 34473230
Nature. 2018 May;557(7706):575-579
pubmed: 29769722
Immunity. 1999 Dec;11(6):733-42
pubmed: 10626895
Nature. 2006 Feb 9;439(7077):682-7
pubmed: 16382236
J Immunol. 2018 Jan 15;200(2):375-383
pubmed: 29311378
Int Immunol. 1998 Oct;10(10):1563-72
pubmed: 9796923
J Immunol. 2014 Mar 15;192(6):2689-98
pubmed: 24510963
Nat Med. 2007 Mar;13(3):354-60
pubmed: 17334371
Science. 1996 Jun 28;272(5270):1947-50
pubmed: 8658169
Immunity. 2012 Sep 21;37(3):549-62
pubmed: 22940097
J Clin Invest. 2013 Jun;123(6):2604-15
pubmed: 23676462
J Infect Dis. 1993 Sep;168(3):725-9
pubmed: 8394863
Trends Immunol. 2018 Dec;39(12):1021-1035
pubmed: 30413351
J Exp Med. 2015 Jun 29;212(7):1125-37
pubmed: 26034050
Immunity. 2018 Jan 16;48(1):161-173.e5
pubmed: 29305140
Nat Rev Immunol. 2014 Jan;14(1):24-35
pubmed: 24336101
Exp Mol Med. 2020 Aug;52(8):1255-1263
pubmed: 32859954
Nat Rev Immunol. 2009 Jul;9(7):514-9
pubmed: 19543226
Cell Rep. 2020 Jun 30;31(13):107827
pubmed: 32610128
Blood. 2012 Mar 29;119(13):3073-83
pubmed: 22251483
J Virol. 2000 Apr;74(8):3650-8
pubmed: 10729141
J Clin Invest. 2001 Jul;108(1):51-62
pubmed: 11435457
Cytokine Growth Factor Rev. 2017 Aug;36:99-105
pubmed: 28629761
Crit Rev Immunol. 2016;36(1):57-74
pubmed: 27480902
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
J Immunol. 2021 Feb 1;206(3):455-462
pubmed: 33468558
Sci Transl Med. 2012 Jun 6;4(137):137ra74
pubmed: 22674552
Immunol Today. 1990 Apr;11(4):113-5
pubmed: 2187466
J Immunother Cancer. 2020 May;8(1):
pubmed: 32467299